FUJIFILM Diosynth Biotechnologies

Home      Contact Us     Careers     Site Map          LinkedIn Facebook

     Home    Process Development    pAVEway™   
cGMP Manufacturing at 1000L scale

The efficient expression of a therapeutic protein is often a bottleneck in the production of biopharmaceuticals. Our pAVEway™ advanced protein platform is an innovative technology for the production of proteins in bacteria, and has been proven in more than 60 biologics, including those which are difficult to express.

To view our pAVEway™ brochure click here

Click here to listen to our webinar: How to achieve industry-leading titers of proteins in E.Coli in six weeks'

pAVEway™ - the benefits



Cost savings



Proven technology

The pAVEway™ platform is based on a set of unique protein expression plasmids, which have been developed by FUJIFILM Diosynth Biotechnologies.

Using DNA looping to control protein expression, we have created a range of vectors which provide tightly controlled production of the target proteins, whilst allowing very high expression levels. These vectors are complemented by a range of host strains.

By choosing the appropriate combination of vector, host strain and microbial fermentation conditions, very high titers have been obtained for soluble, insoluble or secreted proteins.

Evaluation study

FUJIFILM Diosynth Biotechnologies offers to perform a quick evaluation study of the pAVEway™ technology for your protein. This will take about six weeks and will look at intracellular and secreted protein production.

Home   About us   Process Development   GMP Contract Manufacturing   Working with Us   Quality   Careers   Contact Us   Site Map

Copyright 2015 FUJIFILM Diosynth Biotechnologies UK Ltd.

Legal Statement and Disclaimer

We use cookies to help understand how people use our website. By using our site, you agree to our use of cookies. Find out more in our privacy policy.